Science Reveals a Brain Cancer Weakness That Could Prevent Recurrence

العلم يكشف نقطة ضعف بسرطان الدماغ قد تمنع عودته
Brain cancer

Significantly suppressing the disease before it regrows

Studies conducted on mice indicate a brief window of time following surgery for incurable brain cancer during which drugs can cross the brain's protective barrier and reach the residual cancer cells likely to cause the disease to return.

Glioblastoma removal surgery is typically performed within days of diagnosis, with chemotherapy and radiation therapy beginning four to six weeks later. Some cancer cells inevitably remain, and this delay gives them time to grow. Chemotherapy and radiation have limited effectiveness in eliminating these residual cells, leading to tumor recurrence.

Brain cancer

After removing glioblastomas in mice, researchers discovered that the area where the tumor had been removed—known as the resection margin—experienced a disruption in the blood-brain barrier during the initial hours post-surgery, followed by a second disruption 48 to 72 hours later.

A report published in the scientific journal *Science Translational Medicine* showed that drug-carrying nanoparticles were able to accumulate at the resection margin—the area most prone to tumor recurrence—during these periods. 

When the blood-brain barrier was most disrupted after surgery, the delivery of nanoparticles loaded with the chemotherapy drug doxorubicin became more effective, helping to curb tumor recurrence. 

"For the first time, we have shown that glioblastoma surgery briefly reveals a vulnerability we can exploit," said Dr. Thomas Kessby, a study co-author from the University of Manchester in the UK, in a statement. He added, "If treatment is synchronized with the specific time windows we identified, it can significantly suppress the disease before it regrows."

No comments

Powered by Blogger.